Loading...

Follow The End of Hair Loss and Balding by 2020 on Feedspot

Continue with Google
Continue with Facebook
or

Valid
No matter how many years I research hair loss, virtually every month still brings a major surprise. The latest eyebrow-raising story ..read more
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
Update: Revian Red September 2019 Press Release. Revian Red Light Therapy for Hair Growth.It has been a long time since I wrote a post on ..read more
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
Oral Minoxidil Hair Growth.Since I first wrote this post on oral Minoxidil several years ago, a number of major new developments have ..read more
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
I have covered Italian company Cassiopea numerous times on this blog. Primarily due to its Breezula topical product for male pattern hair ..read more
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
I have covered Samumed (US) close to 20 times on this blog. In 2018, the company started Phase 3 clinical trials for its androgenetic ..read more
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
For those of us who have been following hair loss cure research for the past half decade, the number one person of interest is Japan’s ..read more
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
Rogaine (chemical name Minoxidil) is one of only two officially approved hair loss treatments in the US and EU. There are a number of ..read more
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
I first covered UK-based HairClone in 2016. Later in the same year, HairClone’s very friendly CEO Dr. Paul Kemp kindly answered a number ..read more
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
Yesterday, Aclaris announced that their oral  ATI-501 JAK 1/3 inhibitor Phase 2 clinical trials were successful in treating patients with ..read more
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
The media is continuing its frenetic coverage of the two big news items from a month ago in relation to: Stemson Therapeutics and its ..read more

Read for later

Articles marked as Favorite are saved for later viewing.
close
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Separate tags by commas
To access this feature, please upgrade your account.
Start your free month
Free Preview